ZYBT
Zhengye Biotechnology Holding Limited Ordinary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
ZYBT Stock Analysis: Buy, Sell, or Hold?
$1.49
-0.01 (-0.67%)
▼
5d:
+12.03%
30d:
-13.87%
90d:
-7.45%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (77%)
Quality Score
56/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$1.26 – $1.55
Position: SLIGHTLY HIGH
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.17 / $1.59
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: ZYBT shows positive signals but monitor for confirmation. Moderate conviction.
Get Alerted When ZYBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ZYBT is currently trading at $1.49, which is considered slightly high relative to its 30-day fair value range of $1.26 to $1.55.
Technical Outlook: Technically, ZYBT is showing sideways momentum. Immediate support is located at $1.17, while resistance sits at $1.59.
Market Sentiment: ZYBT scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZYBT is showing sideways momentum. Immediate support is located at $1.17, while resistance sits at $1.59.
Market Sentiment: ZYBT scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.26 -
$1.55
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.5%
Trading Range & Key Levels
30-Day Trading Range
$1.26 -
$1.55
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$1.17
Resistance Level
$1.59
Current Trend
Sideways
Technical data as of
Nov 9, 2026
Quantitative Signal Breakdown
- BULLISH: Strong technical setup (67/100)
- BULLISH: High volume confirmation
- BULLISH: Bottoming setup score 67/100 — corrected, stabilizing, and turning up
Fundamental Context
Revenue Growth (YoY)
-40.9%
Earnings Growth (YoY)
-79.6%
Profit Margin
-60.0%
Share ZYBT Analysis
Share this live ZYBT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ZYBT)
Bullish
3 Retail Mentions
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Oct 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Traders on StockTwits express bullish sentiment towards $ZYBT, with some increasing their positions and expressing optimism about potential price gains.
Key Retail Themes:
Bullish sentiment
Price optimism
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 6:18 AM ET
Data refreshes hourly during market hours. Next update: 7:18 AM
Data refreshes hourly during market hours. Next update: 7:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZYBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 27 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 34 SELL |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 49 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 34 SELL |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ZYBT Research Pages
